Viking Therapeutics Stock: A Speculative Buy (NASDAQ:VKTX)
Seeking Alpha· 2025-10-04 13:44
In this article, I will explain—using back-of-the-envelope math and plain English—why the stock of Viking Therapeutics, Inc. (NASDAQ: VKTX ), one of the frontrunners in the GLP-1 weight-loss drug market, may represent a (relatively) de-risked investment opportunityI am a corporate lawyer with an MBA and a long-standing interest in value investing. After spending 7 years practicing at several prestigious Wall Street and Silicon Valley law firms as a corporate transactional lawyer, I founded and have been ope ...
Viking Therapeutics: A Speculative Buy
Seeking Alpha· 2025-10-04 13:44
In this article, I will explain—using back-of-the-envelope math and plain English—why the stock of Viking Therapeutics, Inc. (NASDAQ: VKTX ), one of the frontrunners in the GLP-1 weight-loss drug market, may represent a (relatively) de-risked investment opportunityI am a corporate lawyer with an MBA and a long-standing interest in value investing. After spending 7 years practicing at several prestigious Wall Street and Silicon Valley law firms as a corporate transactional lawyer, I founded and have been ope ...
SHAREHOLDER RIGHTS ALERT: Halper Sadeh LLC Investigates ODP and AL on Behalf of Shareholders
Globenewswire· 2025-10-04 13:39
NEW YORK, Oct. 04, 2025 (GLOBE NEWSWIRE) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: ODP Corporation (NASDAQ: ODP)’s sale to an affiliate of Atlas Holdings for $28.00 per share in cash. If you are an ODP shareholder, click here to learn more about your rights and options. Air Lease Corporation (NYSE: AL)’s sale to Sumitomo Corporation, SMBC A ...
2 Surefire Dividend Stocks to Buy for the Long Haul
Yahoo Finance· 2025-10-04 13:37
Key Points Novartis and Gilead Sciences have businesses that can perform well during downturns. Novartis has an extensive portfolio of medicines across many therapeutic areas. Gilead Sciences leads the HIV market and is expanding its oncology lineup. 10 stocks we like better than Novartis › Equity markets experienced significant volatility this year. Many investors feared that President Donald Trump's aggressive trade policies would plunge the economy into a recession and lead to a full-blown sto ...
Pink Floyd’s ‘Wish You Were Here’ Album Returning
Forbes· 2025-10-04 13:36
The album that consolidated Pink Floyd’s superstar status fifty years ago receives an anniversary box set treatment.(L-R) A member of staff poses in front of the back cover image outtake of the album 'Wish you were Here', a photograph by Storm Thorgerson featured on the inside of the album 'Wish you were Here' and the front cover picture of the album 'Wish you were Here' by Aubrey 'Po' Powell in Hollywood during a photocall at the 'The Pink Floyd Exhibition: Their Mortal Remains' at the Victoria and Albert ...
Robinhood Lists Strategy’s Preferred Stocks Including STRC — and Why This Matters for Bitcoin
Yahoo Finance· 2025-10-04 13:32
Robinhood’s decision to list Strategy’s four preferred stocks marks a rare break from its own investment policies — and could strengthen Michael Saylor’s bitcoin playbook without diluting holders of the firm’s common stock, MSTR. The brokerage began offering trading in four Strategy (MSTR) preferred stocks on Oct. 2, with tickers STRC, STRD, STRF, and STRK now available on the platform. The next day, CEO Vlad Tenev confirmed the move on X, saying Robinhood had “heard from many Strategy investors that t ...
Why Take-Two Interactive Stock Zoomed Almost 11% Higher in September
Yahoo Finance· 2025-10-04 13:30
Key Points It released the latest title in one of its franchises, and take-up was brisk. The game had a large army of players less than a week after its release. 10 stocks we like better than Take-Two Interactive Software › The ninth month of 2025 was an eventful period for the video game industry generally, and sector stalwart Take-Two Interactive Software (NASDAQ: TTWO) in particular. In mid-September, the company released the long-awaited sequel to one of its titles, and later in the month, its ...
Gibbs: Small Cap Earnings Can Double SPX in 2026
Youtube· 2025-10-04 13:30
Now we take a look at the big picture. Aaron Gibbs, chief equity strategist at Fleetstone is with us. How are you feeling about the market today and going forward, Aaron.Well, certainly when we're talking about those large caps, it's been an interesting rotation and I am definitely concerned. Uh it's not 100% sure how we'll get through October. Uh and obviously uh the Fed meeting is uh sorry the the shutdown as well as the Fed meeting is going to be interesting for these next this next month at least.Um but ...
Fair Issac Vs. Equifax: The Credit Score War Has Begun (NYSE:EFX)
Seeking Alpha· 2025-10-04 13:30
"Your Fair Isaac Corporation (NYSE: FICO )("Fico") article didn't age well". This is how some commented on my recent piece of research, where I revised my rate of Fico fromI’m a long-term investor focused on U.S. and European equities, with a dual emphasis on undervalued growth stocks and high-quality dividend growers. Through years of experience, I’ve learned that sustained profitability—evident in strong margins, stable and expanding free cash flow, and high returns on invested capital—is a more reliable ...
HBAR Price May Fail Breakout As Bitcoin Correlation Falls To 2-Month Low
Yahoo Finance· 2025-10-04 13:29
what is hedera hashgraph HBAR. Photo by BeInCrypto Hedera’s native token, HBAR, is struggling to maintain momentum after a recent rebound failed to generate meaningful gains. Despite briefly attempting to break out of its downward pattern, weakening market conditions and its fading correlation with Bitcoin have raised concerns that the recovery may not hold. Hedera Is Pulling Away From Bitcoin HBAR’s correlation with Bitcoin has slipped to 0.48, its lowest point in two months. This weakening connection ...